How long would you wait to start another biologic agent after Rituximab administration in patients with dermatomyositis and refractory inflammatory arthritis (intolerant to traditional DMARDs)?
Patient with dermatomyositis on rituximab with refractory inflammatory arthritis. Intolerant of traditional DMARDs such as methotrexate, leflunomide, hydroxychloroquine, and azathioprine
Answer from: at Academic Institution
The time frame between rituximab infusion and initiation of a different biologic agent depends on the severity of the symptoms. In case of life-threatening complications (like RP-ILD), then rituximab could be given simultaneously with an agent like tofacitinib. If the main symptom though is arthriti...
Sign in or Register to read more